Efficacy Of Bupropion Tablet On Sexual Dysfunction And Quality Of Life In Men With Chronic Kidney Disease

Evaluation The Effect of Bupropion Tablet On Sexual Dysfunction And Quality Of Life In Men With Chronic Kidney Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011732012N1

Enrollment

Registered

2017-02-01

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction. Male Erectile Dysfunction, Unspecified

Interventions

Intervention 1: 20 Patients: Tablet Bupropion 100mg For 10 Weeks. Intervention 2: 20 Patients: Placebo For 10 Weeks.

Treatment - Drugs

Placebo

20 Patients: Tablet Bupropion 100mg For 10 Weeks

20 Patients: Placebo For 10 Weeks

Eligibility

Sex/Gender

Male

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: male patients with chronic kidney disease, age between 25-60 years old who have sexual dysfunction from 6 months ago. Exclusion Criteria: Age older than 60 years; Anatomical penile dysfunction; History of prostatectomy; History of priapism; History of seizure; Head trauma; Organic brain disease; Psychosis; History of alcohol use; Use Monoamino Oxidase inhibitor drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Erectile Dysfunction. Timepoint: First Day and 10 Weeks Later. Method of measurement: IIEF-5 Standard Questionnaire.;Quality Of Life. Timepoint: First Day and 10 Weeks Later. Method of measurement: Quality of Life Questionnaire (WHOQOL-BREF).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bahare Hajsalimi

Zanjan University of Medical Sciences

bhajsalimi@gmail.com+98 24 3342 0459

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026